biostudies-literatureUnknown191(3)Mink van der Molen DR<h4>Purpose</h4>To evaluate perceived access to health care and preferences for health care provision among patients (being) treated for breast cancer during the COVID-19 pandemic.<h4>Methods</h4>Longitudinal study within the prospective, multicenter UMBRELLA cohort of patients (being) treated for breast cancer. All cohort participants enrolled in UMBRELLA between October 2013 and November 2020 were sent a COVID-19-specific survey during the first and second wave of the COVID-19 pandemic, i.e., April 2020 and November 2020, respectively.<h4>Results</h4>In total, 1106 (69.3%) and 822 (50.9%) cohort participants completed the survey in the first and second wave, respectively. The proportion of patients experiencing that their treatment or follow-up care was affected due to COVID-19 decreasedBreast cancer research and treatment553-564https://www.ebi.ac.uk/biostudies/studies/S-EPMC8635319biostudies-literatureThe impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer.PMC8635319Ernst MFvan Stam LEBargon CAYoung-Afat DASier Mvan Dam IEBatenburg MCTSchoenmaeckers EJPDoeksen Avan Dalen TBijlsma RMvan der Leij FMaarse WVerkooijen HMBaas IOMink van der Molen DRon behalf of UMBRELLA study groupfalseThe impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer.<h4>Purpose</h4>To evaluate perceived access to health care and preferences for health care provision among patients (being) treated for breast cancer during the COVID-19 pandemic.<h4>Methods</h4>Longitudinal study within the prospective, multicenter UMBRELLA cohort of patients (being) treated for breast cancer. All cohort participants enrolled in UMBRELLA between October 2013 and November 2020 were sent a COVID-19-specific survey during the first and second wave of the COVID-19 pandemic, i.e., April 2020 and November 2020, respectively.<h4>Results</h4>In total, 1106 (69.3%) and 822 (50.9%) cohort participants completed the survey in the first and second wave, respectively. The proportion of patients experiencing that their treatment or follow-up care was affected due to COVID-19 decreased2022-01-01T00:00:00Z2022 Feb2026-05-09T05:33:11.901Z2022-02-11T14:16:51.454ZS-EPMC86353193485398810.1007/s10549-021-06458-3